Investment
Features
FeesSafety
Academy
More
Pluang+

ZenaTech to open a drone testing facility in Ukraine to validate defense systems in active combat conditions.

Company Fundamentals
07 Apr 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

ZenaTech announced plans to establish a drone testing facility in Ukraine, leveraging the country's intense drone warfare environment to validate its Interceptor P-1 and other defense systems under real operational conditions. This facility complements its existing plans for a manufacturing hub in Ukraine aimed at producing cost-effective counter-drone systems for global defense customers. The move positions ZenaTech to gain credible, battle-tested data and accelerate product development, targeting defense clients in the US, Gulf states, and NATO allies. The company is working with Ukrainian authorities to ensure compliance and streamline testing approvals under martial law regulations.

More News

Investors in Putnam mutual funds may claim losses in a new class action lawsuit.

Investors in Putnam mutual funds may claim losses in a new class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...

Market News
Bearish
41 minutes ago
Stocks fall sharply due to legal probes, financing plans, and volatile listings today.

Stocks fall sharply due to legal probes, financing plans, and volatile listings today.

Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...

Market News
Bearish
1 hour ago
Study finds 2 years of lenalidomide maintenance as effective as indefinite treatment for multiple myeloma.

Study finds 2 years of lenalidomide maintenance as effective as indefinite treatment for multiple myeloma.

The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...

Company Fundamentals
Neutral
1 hour ago
Stock market jumps on strong corporate news and high trading volumes in EV and green energy sectors

Stock market jumps on strong corporate news and high trading volumes in EV and green energy sectors

The stock market saw significant gains driven by corporate announcements and high trading volumes, particularly in battery technology, electric vehicles, and green energy sectors. Electrovaya surged 49.05% after announcing a commercial deal with Amaz...

Market News
Bullish
1 hour ago
Akamai officer sells shares amid shift to cloud and cybersecurity growth

Akamai officer sells shares amid shift to cloud and cybersecurity growth

An Akamai Technologies executive sold 3,100 shares as the company shifts focus from its declining content delivery network business to high-growth cloud infrastructure and cybersecurity services. This strategic pivot is supported by a $1.8 billion, s...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App